Patient perceptions of artificial intelligence in breast disease management: a cross-sectional survey in China
Patient:innenwahrnehmung künstlicher Intelligenz in der Behandlung von Brusterkrankungen: Querschnittsbefragung in China
Frontiers in Public Health · 12.11.2026 · 14
DOI: 10.3389/fpubh.2026.1973242 ↗Auf einen Blick
Eine Online-Befragung von 457 Patient:innen nach Brustoperation zeigte eine hohe Akzeptanz von KI-Tools in der Behandlung von Brusterkrankungen. Gleichzeitig bestanden Bedenken zu emotionaler Unterstützung, Privatsphäre und Genauigkeit.
Fragestellung
Welche Einstellungen haben Patient:innen zu KI-Tools in der Behandlung von Brusterkrankungen, und wie beeinflussen Alter und Bildung die Bereitschaft zur Nutzung?
Methode
Querschnittliche, online gestützte Fragebogenstudie bei Patient:innen nach Brustoperation am PUMCH in China; Erhebung von März bis Mai 2025.
Ergebnisse
457 von 530 Eingeladenen nahmen teil (86,2 %). 91,7 % fanden KI zumindest „etwas hilfreich“. 86,0 % würden KI für die Vordiagnose und 92,1 % für Triage nutzen; 70,0 % für Diagnose- und Behandlungsunterstützung.
Einschränkungen
Nur eine Klinik; Online-Befragung.
Schlussfolgerung der Autor:innen
Die Befragten zeigten eine starke Akzeptanz von KI in der Behandlung von Brusterkrankungen. Genannt werden jedoch Bedenken zu emotionaler Unterstützung, Privatsphäre und Genauigkeit.
Kernaussagen
- 91,7 % bewerteten KI als zumindest „etwas hilfreich“
- 86,0 % Vordiagnose, 92,1 % Triage, 70,0 % Diagnose-/Behandlungsunterstützung
- Ältere und höher gebildete Patient:innen bewerteten KI tendenziell negativer
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Querschnittstudie in der Zeitschrift Frontiers in Public Health, online erschienen am 12.11.2026. Verfasst von Ying Xu und 4 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Artificial intelligence (AI) tools are increasingly integrated into healthcare, yet patient perceptions—particularly in breast disease management—remain underexplored. Understanding these attitudes is critical for optimizing AI implementation and addressing disparities in trust and acceptance.
Objective
To assess patient attitudes toward AI tools in breast disease management and identify how age and education influence willingness to adopt AI in clinical settings in China.
Methods
A cross-sectional, online, questionnaire-based survey was conducted among patients who underwent surgery for breast diseases in the Department of Breast Surgery at Peking Union Medical College Hospital (PUMCH) through the wenjuanxing application (a survey platform) from March to May 2025. Of 530 invited participants, 457 (response rate: 86.2%) completed the questionnaire, which evaluated prior AI use, trust levels, concerns, and willingness to engage with AI tools. Primary outcomes included perceptions of AI utility, trust in AI versus physician recommendations, privacy concerns, and willingness to use AI for pre-diagnosis, triage, and clinical decision support.
Results
Among participants, 91.7% found AI tools at least “somewhat helpful,” though 66.7% cited lack of emotional support as a key drawback. When AI and physician advice conflicted, 50.8% fully trusted doctors, while 43.3% preferred integrating both. Willingness to use AI was high for pre-diagnosis (86.0%) and precise triage (92.1%), but lower for clinical diagnosis and treatment assistance (70.0%). Patients across different age groups and educational levels hold generally similar views on AI tools, yet distinct tendencies emerge among subgroups. Multivariable ordinal logistic regression revealed that patients aged over 45 tended to hold more negative evaluations of AI tools, whereas younger individuals showed more positive attitudes. Meanwhile, those with postgraduate education or above tended to express more negative attitudinal sentiment toward AI tools. Conclusion and relevance Patients in this survey demonstrated strong acceptance of AI in breast disease management, but concerns about emotional support, privacy, and accuracy persist. Demographic variations highlight the need for tailored implementation strategies, including transparency protocols and equitable design. Furthermore, these findings provide valuable policy and ethical implications for establishing standardized AI disclosure mechanisms and optimizing human–AI collaborative clinical models, aiming to facilitate patient-centered AI integration and improve the clinical practicality of medical artificial intelligence.
Zitieren
APA
Xu, Y., Song, Y., Mao, F., Zhou, Y., & Zhang, Y. (2026). Patient perceptions of artificial intelligence in breast disease management: a cross-sectional survey in China. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1973242
Vancouver
Xu Y, Song Y, Mao F, Zhou Y, Zhang Y. Patient perceptions of artificial intelligence in breast disease management: a cross-sectional survey in China. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1973242
BibTeX
@article{Xu2026,
author = {Xu, Ying and Song, Yu and Mao, Feng and Zhou, Yidong and Zhang, Yanna},
title = {Patient perceptions of artificial intelligence in breast disease management: a cross-sectional survey in China},
journal = {Frontiers in Public Health},
year = {2026},
volume = {14},
doi = {10.3389/fpubh.2026.1973242}
}
EUVIMED